Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition and use for applying ribociclib in phosphodiesterase 4-mediated disease treatment of patient and inhibition of phosphodiesterase 4 activity

Pharmaceutical composition and use for applying ribociclib in phosphodiesterase 4-mediated disease treatment of patient and inhibition of phosphodiesterase 4 activity

US Patent 11351172 · Granted Jun 7, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Display apparatus2025
9,11-secosteroids and the use of 9,11-secosteroids in preparing pharmaceutical c2025
Methods for the treatment of diseases associated with activation of inflammasome2024
Method for inhibiting infection of SARS-CoV-2 in a subject2023
Maca extract and use thereof2023
Packet processing system and packet processing method thereof for detecting micr2022
Neutrophil inflammation inhibitor and uses thereof2020
Signal-repeating device for extending a control area and signal-repeating method2019
Formyl peptide receptor 1 antagonists and uses thereof2018
FPR1 antagonist derivatives and use thereof2017
Oxime-based compound, pharmaceutical composition containing the same and method 2015
Portable electrical device2014